Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
0.3564
-0.0064 (-1.76%)
May 13, 2025, 4:00 PM - Market closed
Sensei Biotherapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 9.88 | 9.99 | 13.01 | 17.8 | 7.16 | 16.6 | Upgrade
|
| Short-Term Investments | 24.45 | 31.34 | 52.75 | 89.32 | 140.46 | - | Upgrade
|
| Cash & Short-Term Investments | 34.33 | 41.34 | 65.76 | 107.12 | 147.62 | 16.6 | Upgrade
|
| Cash Growth | -40.89% | -37.14% | -38.61% | -27.44% | 789.50% | 6511.95% | Upgrade
|
| Prepaid Expenses | 0.91 | 0.47 | 1.17 | 1.13 | 0.55 | 1.38 | Upgrade
|
| Other Current Assets | 0.44 | 0.12 | 0.33 | 0.34 | 0.37 | 2.11 | Upgrade
|
| Total Current Assets | 35.68 | 41.93 | 67.25 | 108.59 | 148.54 | 20.08 | Upgrade
|
| Property, Plant & Equipment | 2.57 | 3.38 | 7.04 | 9.72 | 4.64 | 1.27 | Upgrade
|
| Other Long-Term Assets | 0.02 | 0.05 | 0.09 | 0.06 | 0.04 | 0.09 | Upgrade
|
| Total Assets | 38.27 | 45.36 | 74.37 | 118.38 | 153.23 | 21.43 | Upgrade
|
| Accounts Payable | 2.36 | 0.24 | 0.57 | 4.47 | 2.46 | 3.88 | Upgrade
|
| Accrued Expenses | 0.72 | 2.73 | 2.41 | 2.46 | 1.75 | 0.92 | Upgrade
|
| Current Portion of Leases | 2.15 | 2.32 | 2.44 | 2.13 | 0.68 | 0.03 | Upgrade
|
| Other Current Liabilities | - | 0.16 | 0.22 | - | - | - | Upgrade
|
| Total Current Liabilities | 5.23 | 5.45 | 5.64 | 9.07 | 4.89 | 4.83 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 0.57 | Upgrade
|
| Long-Term Leases | 1.06 | 1.53 | 3.77 | 5.9 | 1.67 | 0.09 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.07 | - | 0.15 | 0.05 | Upgrade
|
| Total Liabilities | 6.29 | 6.98 | 9.48 | 14.97 | 6.71 | 5.54 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | - | Upgrade
|
| Additional Paid-In Capital | 300.91 | 300.45 | 297 | 302.2 | 296.05 | 55.97 | Upgrade
|
| Retained Earnings | -268.92 | -262.05 | -231.9 | -197.79 | -149.21 | -112.41 | Upgrade
|
| Comprehensive Income & Other | -0.01 | -0.01 | -0.21 | -1 | -0.33 | - | Upgrade
|
| Total Common Equity | 31.99 | 38.39 | 64.9 | 103.41 | 146.51 | -56.44 | Upgrade
|
| Shareholders' Equity | 31.99 | 38.39 | 64.9 | 103.41 | 146.51 | 15.89 | Upgrade
|
| Total Liabilities & Equity | 38.27 | 45.36 | 74.37 | 118.38 | 153.23 | 21.43 | Upgrade
|
| Total Debt | 3.21 | 3.85 | 6.21 | 8.03 | 2.35 | 0.69 | Upgrade
|
| Net Cash (Debt) | 31.12 | 37.49 | 59.55 | 99.08 | 145.27 | 15.91 | Upgrade
|
| Net Cash Growth | -40.65% | -37.04% | -39.90% | -31.79% | 813.00% | - | Upgrade
|
| Net Cash Per Share | 1.24 | 1.49 | 2.13 | 3.23 | 5.24 | 9.87 | Upgrade
|
| Filing Date Shares Outstanding | 25.21 | 25.21 | 25.07 | 30.97 | 30.68 | 30.59 | Upgrade
|
| Total Common Shares Outstanding | 25.21 | 25.18 | 25.03 | 30.76 | 30.61 | 1.88 | Upgrade
|
| Working Capital | 30.45 | 36.48 | 61.61 | 99.52 | 143.65 | 15.25 | Upgrade
|
| Book Value Per Share | 1.27 | 1.52 | 2.59 | 3.36 | 4.79 | -30.10 | Upgrade
|
| Tangible Book Value | 31.99 | 38.39 | 64.9 | 103.41 | 146.51 | -56.44 | Upgrade
|
| Tangible Book Value Per Share | 1.27 | 1.52 | 2.59 | 3.36 | 4.79 | -30.10 | Upgrade
|
| Machinery | - | 1.66 | 2.64 | 3.24 | 5.58 | 1.86 | Upgrade
|
| Leasehold Improvements | - | 0.25 | 0.25 | 0.25 | 0.25 | - | Upgrade
|
Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.